JC virus-associated central nervous system diseases in HIV-infected patients in Brazil: Clinical presentations, associated factors with mortality and outcome

Brazilian Journal of Infectious Diseases

Volumn 16, Issue 2, 2012, Pages 153-156

  Piza, Felipe ^a   Fink, Maria Cristina ^b   Nogueira, Gilberto S ^a   Pannuti, Claudio S ^b   Penalva de Oliveira, Augusto C ^a   Vidal, José Ernesto ^a  

^a INSTITUTO DE INFECTOLOGIA EMÍLIO RIBAS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Acquired immunodeficiency syndrome; Brazil; Diagnosis; JC virus; Leukoencephalopathy, progressive multifocal

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; BRAZIL; CENTRAL NERVOUS SYSTEM DISEASE; CEREBELLUM DISEASE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; GAIT DISORDER; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; JC VIRUS ASSOCIATED CENTRAL NERVOUS SYSTEM DISEASE; JC VIRUS GRANULE CELL NEURONOPATHY; MALE; MORTALITY; NONHUMAN; NOSOCOMIAL PNEUMONIA; OUTCOME ASSESSMENT; PNEUMONIA; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; RETROSPECTIVE STUDY; SEIZURE; SPEECH DISORDER; VISUAL DISORDER; WEAKNESS;

EID: 85027943964     PISSN: 14138670     EISSN: 16784391     Source Type: Journal    
DOI: 10.1016/S1413-8670(12)70297-0     Document Type: Article

References (24)

1. D'Arminio Monforte A., Cinque P., Mocroft A., et al. Changing incidence of central nervous system diseases in the EuroSIDA cohort. Ann Neurol 2004, 55:320-328.
2. Sacktor N. The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy. J. Neurovirol 2002, 8(suppl. 2):115-121.
3. Berger J.R. Progressive multifocal leukoencephalopathy in acquired immunodeficiency syndrome: explaining the high incidence and disproportionate immunosuppressive conditions. J Neurovirol 2003, 9(suppl.1):38-41.
4. Vidal J.E., Penalva de Oliveira A.C., Fink M.C., et al. AIDS-related progressive multifocal leukoencephalopathy: a retrospective study in a referral center in Sao Paulo. Brazil. Rev Inst Med Trop 2008, 50:209-212.
5. Oliveira J.F., Greco D.B., Oliveira G.C., et al. Neurological disease in HIV-infected patients in the era of highly active antiretroviral treatment: a Brazilian experience. Rev Soc Bras Med Trop 2006, 39:146-151.
6. Cinque P., Koralnik I.J., Clifford D. The evolving face of human immunodeficiency virus-related progressive multifocal leukoencephalopathy: defining a consensus terminology. J Neurovirol 2003, 9(suppl.1):88-92.
7. Koralnik I.J. Progressive multifocal leukoencephalopathy revisited: has the disease outgrown its name?. Ann Neurol 2006, 60:162-173.
8. Brew B.J., Davies N.W., Cinque P., et al. Progressive multifocal leukoencephalopathy and other forms of JC virus disease. Nat Rev Neurol 2010, 6:667-679.
9. Gasnault J., de Goer de Herve M.G., Rahoiljaon J., et al. Early brainstem damage is predictive of poor survival in HIV-infected patients with progressive multifocal leukoencephalopathy. XI Conference on Retrovirus and Opportunistic Infections 2004, Poster G-20.
10. Cinque P., Koralnik I., Gerevini S., et al. Progressive multifocal leukoencephalopathy in HIV-1 infection. Lancet Infect Dis 2009, 9:625-636.
11. Tan K., Roda R., Ostrow L., et al. PML-IRIS in patients with HIV infection. Neurology 2009, 72:1458-1464.
12. Koralnik I.J. New insights into progressive multifocal leukoencephalopathy. Curr Opin Neurol 2004, 17:365-370.
13. Cinque P., Bossolasco A.S., Brambilla A.M., et al. The effect of highly active antiretroviral therapy-induced immune reconstitution on development and outcome of progressive multifocal leukoencephalopathy: study of 43 cases with review of the literature. J Neurovirol 2003, 9(suppl.1):1-8.
14. Du Pasquier R.A., Corey S., Margolin D.H., et al. Productive infection of cerebellar granule cell neurons by JC virus in an HIV+ individual. Neurology 2003, 61:775-782.
15. Koralnik I.J., Wuthrich C., Dang X., et al. JC virus granule cell neuronopathy: a novel clinical syndrome distinct from progressive multifocal leukoencephalopathy. Ann Neurol 2005, 57:576-580.
16. Dang X., Koralnik I.J. A granule cell neuron-associated JC virus variant has a unique deletion in the VP1 gene. J Gen Virol 2006, 87:2533-2537.
17. Dang X., Vidal J.E., de OIiveira A.C., et al. JC virus granule cell neuronopathy is associated with VP1 C terminus mutants. J Gen Virol 2012, 93(Pt 1):175-183.
18. Wuthrich C., Cheng Y.M., Joseph F.T., et al. Frequent infection of cerebellar granule cell neurons by polyomavirus JC in progressive multifocal leukoencephalopathy. J Neuropathol Exp Neurol 2008, 68:15-25.
19. Antinori A., Cingolani A., Lorenzini P., et al. Clinical epidemiology and survival of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy: data from the Italian Registry Investigative Neuro AIDS (IRINA). J Neurovirol 2003, 9(suppl. 1):47-53.
20. Gasnault J., Taoufik Y. New trends in progressive multifocal leukoencephalopathy. Rev Neurol (Paris) 2006, 162:43-56.
21. Marzocchetti A., Tompkins T., Clifford D.B., et al. Determinants of survival in progressive multifocal leukoencephalopathy. Neurology 2009, 73:1551-1558.
22. Engsig F.N., Hartsen A.B.E., Omland L.H., et al. Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a nationwide cohort study. Clin Infect Dis 2009, 199:77-83.
23. Lima M.A., Bernal-Cano F., Clifford D.B., et al. Clinical outcome of long-term survivors of progressive multifocal leukoencephalopathy. J Neurol Neurosurg Psychiatry 2010, 81:1288-1291.
24. Vidal J.E., Hernandez A.V., Penalva de Oliveira A.C., et al. Cerebral toxoplasmosis in HIV-positive patients in Brazil: clinical features and predictors of treatment response in the HAART era. AIDS Patient Care and STDS 2005, 19:626-634.